Drug Topics
OCTOBER 8, 2024
Florida-based pharmacist Brad Phillips, PharmD, BCACP, speaks to the importance of pre-planning, emergency refills, medication storage, and post-storm safety measures to ensure medication security during hurricanes.
PharmaVoice
OCTOBER 8, 2024
This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
OCTOBER 10, 2024
Intravenous fluid shortages appear to be affecting the majority of the nation’s healthcare providers, who as a result are already beginning to cancel procedures, survey data published Thursday show | Premier said 86% of its provider members are reporting shortages, and more than half have less than 10 days supply on hand. Respondents also said they were beginning or considering procedure cancellations, and have begun receiving solicitations from "unapproved, gray market suppliers.
Fierce Pharma
OCTOBER 11, 2024
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a deal is indeed brewing. | Sanofi has entered negotiations with private equity outfit Clayton, Dubilier & Rice to potentially sell a 50% controlling stake in its consumer health business, Opella. Sanofi first telegraphed plans to separate its consumer health arm last October.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 11, 2024
Individuals living in rural areas can benefit from pharmacy-based pre-exposure prophylaxis programs.
PharmaVoice
OCTOBER 7, 2024
Through real-world data, an AI company found that popular weight loss drugs could be a preventive measure for patients at risk of heart attack and stroke.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Pharma
OCTOBER 11, 2024
A little over four years after being sued by the United States, Teva is putting longstanding allegations that it paid kickbacks on a popular multiple sclerosis drug to bed. | Teva Pharmaceuticals USA and Teva Neuroscience have agreed to pay a combined $450 million to resolve claims that the company violated the United States' Anti-Kickback Statute and the False Claims Act, the U.S.
Drug Topics
OCTOBER 8, 2024
Research presented at CHEST 2024 outlined the heart failure risks associated with COVID-19 infection and emphasized the importance of vaccination to prevent adverse outcomes.
PharmaVoice
OCTOBER 9, 2024
Small biotechs are making gains with AI drug development, and their advantages may help some push ahead without Big Pharma.
STAT
OCTOBER 9, 2024
UnitedHealth Group and CVS Health have petitioned a federal judge to sideline Federal Trade Commission Chair Lina Khan and the two Democratic FTC commissioners from the agency’s lawsuit against the country’s largest pharmacy benefit managers. Attorneys for UnitedHealth’s Optum Rx and CVS Caremark contend Khan, Rebecca Kelly Slaughter, and Alvaro Bedoya “have made repeated incorrect prejudgments” about the PBMs as well as their group purchasing organizations tha
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
OCTOBER 11, 2024
This story was reported in partnership with Uncloseted Media, a nonpartisan, investigative, LGBTQ | Ending the HIV epidemic hinges on both treatment and prevention, particularly through access to PrEP. For at-risk individuals living in the U.S. South—where HIV is a daunting reality—PrEP use is very low compared to the number of new HIV cases.
Drug Topics
OCTOBER 9, 2024
Current rules governing lawsuits must be revisited to strike a balance between legitimate and frivolous legal actions against health care providers.
Pharmacy Times
OCTOBER 11, 2024
This approval marks the first and only anti-tissue factor pathway inhibitor approved in the US for the treatment hemophilia A or B, and the first approved hemophilia treatment to be administered via a pre-filled, auto-injector pen.
STAT
OCTOBER 11, 2024
Recently, California Gov. Gavin Newsom granted $130.7 million for local governments addressing homelessness, including clearing encampments. It comes in the wake of a June Supreme Court ruling that gave cities full authority to implement and enforce policies that would allow them to clear encampments as they see fit. In early August, Newsom was even filmed removing homeless people’s belongings from public view in Mission Hills in Los Angeles County.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
OCTOBER 11, 2024
Wolters Kluwer Health, a big player in clinical decision support solutions, is teaming up with Abridge to integrate UpToDate into its AI-based medical note-taking tool. | Wolters Kluwer Health, a big player in clinical decision support solutions, is teaming up with Abridge to integrate UpToDate into its AI-based medical note-taking tool.
Drug Topics
OCTOBER 9, 2024
On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.
Pharmacy Times
OCTOBER 7, 2024
Eligible patients can receive a 30-day supply of covered drugs and medical supplies that can be renewed every 30 days for as long as an Emergency Prescription Assistance Program (EPAP) is active.
STAT
OCTOBER 8, 2024
On June 17, He Jiankui received an email that wasted no time getting to the point: An American cryptocurrency entrepreneur had learned about the Chinese scientist’s recent proposal to use CRISPR gene-editing technology on human embryos to lower their future risk of developing Alzheimer’s disease, and he was offering funding and other help to turn those plans into a new commercial venture. He rose to international infamy in 2018, when it came to light that he
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
OCTOBER 7, 2024
A rapidly intensifying Hurricane Milton has Florida and its healthcare providers gearing up for another severe weather event less than two weeks after similar preparations for Hurricane Helene. | Facing a second major storm within two weeks, some hospitals on Florida's Gulf Coast are again closing up shop and transferring patients across the state.
Drug Topics
OCTOBER 7, 2024
A roundtable session discussed the real-world implications of applying DIR fees at the point of sale rather than through retroactive clawback.
Pharmacy Times
OCTOBER 11, 2024
Female and older patients had a greater incidence of herpes zoster ophthalmicus and were more likely to develop ocular complications.
STAT
OCTOBER 7, 2024
From the earliest days of the H5N1 bird flu outbreak in dairy cattle, experts watching the evolving situation have worried about California. The Golden State has the country’s largest concentration of dairy farms, roughly 1,100 herds. The concern has been if the virus got into California, the prospects for spread would be huge and containment a challenge.
Fierce Healthcare
OCTOBER 6, 2024
U.S. | U.S. hospitals are taking steps to conserve their supplies of intravenous (IV) fluids as one of the country's biggest manufacturers reduces shipments after Hurricane Helene flooded a major facility in North Carolina.
Drug Topics
OCTOBER 10, 2024
Researchers analyzed the potential role of nonphysician health care providers to provide vaccine services outside of traditional health care settings.
Pharmacy Times
OCTOBER 11, 2024
The exemption allows more time for partners to adhere to enhanced distribution security requirements in the Food, Drug, & Cosmetics Act and prevents possible supply chain disruptions.
STAT
OCTOBER 7, 2024
LONDON — A pair of scientists who discovered a type of RNA molecule that helps control the activity of genes — allowing our cells to perform all their myriad of functions in different tissues throughout the body — won the 2024 Nobel Prize in medicine or physiology on Monday. The award went to Victor Ambros and Gary Ruvkun for their research into microRNA, which the Nobel committee described as a “groundbreaking discovery [that] revealed a completely new principle of g
Fierce Pharma
OCTOBER 7, 2024
After winning a first-in-class nod for its two-drug inhaler Airsupra l | After winning a first-in-class nod for its two-drug inhaler Airsupra last January, AstraZeneca is bolstering the rescue treatment’s clinical package with new data showing it can cut the risk of asthma exacerbations regardless of patients’ disease severity.
Drug Topics
OCTOBER 7, 2024
Although there has recently been an effort to improve pediatric pain treatment, it is still often underestimated and not adequately managed.
Pharmacy Times
OCTOBER 8, 2024
Survodutide is a glucagon/glucagon-like peptide-1 (GLP-1_ receptor dual agonist that activates the glucagon and GLP-1 receptors to better control metabolic function.
STAT
OCTOBER 7, 2024
Over the past 150 years, humanity has unleashed unimaginable energy by splitting atoms and developed machines that allow us to soar through the skies. But arguably, our species’ most profound change has been far more basic: People generally live a lot longer than they used to. This trend has now substantially slowed in wealthier nations, which appear to be nearing a limit in life expectancy improvements from modern medicine, according to a new study.
Fierce Healthcare
OCTOBER 9, 2024
Reports of recent cyberattacks and disruptions in patient care have ticked up among healthcare organizations since 2023, with the average attack bringing just under $1.5 million in operational disr | Ninety-two percent of polled healthcare IT and security practitioners said their organization had faced at least once cyberattack during the prior year.
Drug Topics
OCTOBER 9, 2024
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Anthony Minniti of Bell Pharmacy in Camden, New Jersey, discussed pharmacy in his community and the challenges that come with it.
Pharmacy Times
OCTOBER 7, 2024
Setrusumab could offer a rapid and clinically meaningful decrease in fracture rate in individuals with osteogenesis imperfecta.
Expert insights. Personalized for you.
551 
Let's personalize your content